AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Aromatase Inhibitor Therapy for Non-metastatic Breast Cancer

Clinical trial NCT00089661 · COMPLETED

Trial details

NCT number: NCT00089661
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Breast Cancer Low Bone Mineral Density Osteopenia

Start date: 2004-10-01
Primary completion: 2007-05-11
Enrollment: 252

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.